Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2
R. Camille Brewer, Nitya S. Ramadoss, Lauren J. Lahey, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 33-39
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Applications of single-cell RNA sequencing in drug discovery and development
Bram Van de Sande, Joon Sang Lee, Euphemia Mutasa-Gottgens, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 496-520
Open Access | Times Cited: 207
Towards a population-based threshold of protection for COVID-19 vaccines
David Goldblatt, Andrew Fioré-Gartland, Marina Johnson, et al.
Vaccine (2021) Vol. 40, Iss. 2, pp. 306-315
Open Access | Times Cited: 157
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
Caroline Atyeo, Lydia L. Shook, Sara Brigida, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
Chengzi I. Kaku, Elizabeth Champney, Johan Normark, et al.
Science (2022) Vol. 375, Iss. 6584, pp. 1041-1047
Open Access | Times Cited: 71
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis
R. Camille Brewer, Tobias V. Lanz, Caryn Hale, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 684
Closed Access | Times Cited: 63
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults
Miguel Ángel Palacios-Pedrero, Janina M. Jansen, Cornelia Blume, et al.
Nature Aging (2022) Vol. 2, Iss. 10, pp. 896-905
Open Access | Times Cited: 61
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 42
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 37
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2
Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
Elizabeth M. Anderson, Shuk Hang Li, Moses Awofolaju, et al.
Cell Reports (2022) Vol. 41, Iss. 3, pp. 111496-111496
Open Access | Times Cited: 37
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
Qian Wang, Saumya Anang, Sho Iketani, et al.
Cell Reports (2022) Vol. 39, Iss. 11, pp. 110924-110924
Open Access | Times Cited: 31
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111544-111544
Open Access | Times Cited: 31
Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19low B Cells in Systemic Lupus Erythematosus
Franziska Szelinski, Ana‐Luisa Stefanski, Eva Schrezenmeier, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 9, pp. 1556-1568
Open Access | Times Cited: 29
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants
Isabelle Montgomerie, Thomas W. Bird, Olga R. Palmer, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106256-106256
Open Access | Times Cited: 17
Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants
Shuqi Wang, Peiyang Ding, Lingli Shen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
Xian Li, Mengxin Xu, Jingyi Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
Lil Meyer-Arndt, Julian Braun, Florent Fauchère, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 9, pp. 960-971
Open Access | Times Cited: 28
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics
Lotus L. van den Hoogen, Marije K. Verheul, Eric R. A. Vos, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
CD8+ T cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance
Hiroyasu Aoki, Masahiro Kitabatake, Haruka Abe, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113887-113887
Open Access | Times Cited: 6
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells
Kilian A. Wietschel, Kevin Fechtner, Elmer Antileo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Antibody-mediated immunity to SARS-CoV-2 spike
John M. Errico, Lucas J. Adams, Daved H. Fremont
Advances in immunology (2022), pp. 1-69
Open Access | Times Cited: 21
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
Claudia Gandolfo, Gabriele Anichini, Marco Mugnaini, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 171-171
Open Access | Times Cited: 20
SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination
Shishan Teng, Yabin Hu, You Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 19
B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 11, pp. 3317-3328
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top